Sign up today, get Edge free for 30 days.

Ad free · Full sentiment data · No credit card required

Exchange: TSXV·Updated 02:16 PM EDT

About APLI.TSXV

About

Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7

Frequently Asked Questions

What is Market Cap of Appili Therapeutics Inc - Ordinary Shares - Class A?
What is the 52-week high for Appili Therapeutics Inc - Ordinary Shares - Class A?
What is the 52-week low for Appili Therapeutics Inc - Ordinary Shares - Class A?
What is Appili Therapeutics Inc - Ordinary Shares - Class A stock price today?
What was Appili Therapeutics Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Appili Therapeutics Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Appili Therapeutics Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Appili Therapeutics Inc - Ordinary Shares - Class A?
How many employees does Appili Therapeutics Inc - Ordinary Shares - Class A have?